Search Results - "FOLLATH, Ferenc"

Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine by Gheorghiade, Mihai, Follath, Ferenc, Ponikowski, Piotr, Barsuk, Jeffrey H., Blair, John E.A., Cleland, John G., Dickstein, Kenneth, Drazner, Mark H., Fonarow, Gregg C., Jaarsma, Tiny, Jondeau, Guillaume, Sendon, Jose Lopez, Mebazaa, Alexander, Metra, Marco, Nieminen, Markku, Pang, Peter S., Seferovic, Petar, Stevenson, Lynne W., van Veldhuisen, Dirk J., Zannad, Faiez, Anker, Stefan D., Rhodes, Andrew, McMurray, John J.V., Filippatos, Gerasimos

“…Patients with acute heart failure (AHF) require urgent in‐hospital treatment for relief of symptoms. The main reason for hospitalization is congestion, rather…”
Get full text

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) by Swedberg, Karl, Cleland, John, Dargie, Henry, Drexler, Helmut, Follath, Ferenc, Komajda, Michel, Tavazzi, Luigi, Smiseth, Otto A., Gavazzi, Antonello, Haverich, Axel, Hoes, Arno, Jaarsma, Tiny, Korewicki, Jerzy, Lévy, Samuel, Linde, Cecilia, Lopez-Sendon, José-Luis, Nieminen, Markku S., Piérard, Luc, Remme, Willem J.

Get full text

Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure by Harjola, Veli-Pekka, Follath, Ferenc, Nieminen, Markku S., Brutsaert, Dirk, Dickstein, Kenneth, Drexler, Helmut, Hochadel, Matthias, Komajda, Michel, Lopez-Sendon, Jose L., Ponikowski, Piotr, Tavazzi, Luigi

“…Aims Acute heart failure (AHF) has a poor prognosis. We evaluated 3- and 12-month mortality in different clinical classes of AHF patients from 30 European…”
Get full text

Newer treatments for decompensated heart failure: focus on levosimendan by Follath, Ferenc

“…Acute heart failure (AHF) is a major cause of hospitalizations. Severe dyspnea, pulmonary congestion and low cardiac output with peripheral vasoconstriction…”
Get full text

Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives by Waldhauser, Katri Maria, Török, Michael, Ha, Huy-Riem, Thomet, Urs, Konrad, Daniel, Brecht, Karin, Follath, Ferenc, Krähenbühl, Stephan

“…The aim of this work was to compare hepatocellular toxicity and pharmacological activity of amiodarone (2-n-butyl-3-[3,5…”
Get more information

Acute heart failure: Clinical presentation, one-year mortality and prognostic factors by Rudiger, Alain, Harjola, Veli-Pekka, Müller, Andreas, Mattila, Eero, Säila, Petrus, Nieminen, Markku, Follath, Ferenc

“…Aims Acute heart failure (HF) is a common but ill‐defined clinical entity. We describe patients hospitalised with acute HF in regard of clinical presentation,…”
Get full text

Predictors of short term mortality in heart failure — Insights from the Euro Heart Failure survey by Velavan, Periaswamy, Khan, Nasrin K, Goode, Kevin, Rigby, Alan S, Loh, Poay H, Komajda, Michel, Follath, Ferenc, Swedberg, Karl, Madeira, Hugo, Cleland, John G.F

“…Abstract Objective To identify factors associated with short term mortality in hospitalised patients with heart failure. Background Hospitalisation is frequent…”
Get full text

Clinical Characteristics and Predictors of In-Hospital Mortality in Acute Heart Failure With Preserved Left Ventricular Ejection Fraction by Parissis, John T., MD, Ikonomidis, Ignatios, MD, Rafouli-Stergiou, Pinelopi, MD, Mebazaa, Alexandre, MD, Delgado, Juan, MD, Farmakis, Dimitrios, MD, Vilas-Boas, Fabio, MD, Paraskevaidis, Ioannis, MD, Anastasiou-Nana, Maria, MD, Follath, Ferenc, MD

“…Acute heart failure (AHF) with preserved left ventricular ejection fraction (PLVEF) represents a significant part of AHF syndromes featuring particular…”
Get full text

Electrocardiographic artifacts due to electrode misplacement and their frequency in different clinical settings by Rudiger, Alain, MD, Hellermann, Jens P., MD MSc, Mukherjee, Raphael, Follath, Ferenc, MD, Turina, Juraj, MD

“…Abstract Misplacement of electrodes can change the morphology of an electrocardiogram (ECG) in clinical important ways. To assess the frequency of these errors…”
Get full text

Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition by Zannad, Faiez, Stough, Wendy Gattis, Pitt, Bertram, Cleland, John G.F., Adams, Kirkwood F., Geller, Nancy L., Torp-Pedersen, Christian, Kirwan, Bridget-Anne, Follath, Ferenc

“…Specific criteria have been established to define the occurrence of myocardial infarction (MI) and stroke in cardiovascular clinical trials, but there is not a…”
Get full text

Nonischemic Heart Failure: Epidemiology, Pathophysiology and Progression of Disease by Follath, Ferenc

“…The prevalence of nonischemic heart failure including idiopathic dilative cardiomyopathy is not well known. It may vary considerably in different population…”
Get full text

Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine by Fattinger, Karin, Roos, Malgorzata, Vergères, Patrice, Holenstein, Clemens, Kind, Brigitt, Masche, Urspeter, Stocker, David N., Braunschweig, Suzanne, Kullak‐Ublick, Gerd A., Galeazzi, Renato L., Follath, Ferenc, Gasser, Theo, Meier, Peter J.

“…Aims To explore drug exposure, frequency of adverse drug reactions (ADRs), types of ADRs, predisposing risk factors and ADR‐related excess hospital stay in…”
Get full text

Nonpharmacologic Measures and Drug Compliance in Patients with Heart Failure: Data from the EuroHeart Failure Survey by Lainščak, Mitja, MD, PhD, Cleland, John G.F., MD, PhD, Lenzen, Mattie J., MSc, Keber, Irena, MD, PhD, Goode, Kevin, BEng, PhD, Follath, Ferenc, MD, Komajda, Michel, MD, PhD, Swedberg, Karl, MD, PhD

“…Advice on lifestyle, diet, vaccination, and therapy are part of the standard management of heart failure (HF). However, there is little information on whether…”
Get full text

Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship by Quaglino, Daniela, Ha, Huy Riem, Duner, Elena, Bruttomesso, Daniela, Bigler, Laurent, Follath, Ferenc, Realdi, Giuseppe, Pettenazzo, Andrea, Baritussio, Aldo

“…Amiodarone, an antiarrhythmic drug toxic toward the lung, is metabolized through sequential modifications of the diethylaminoethoxy group to…”
Get more information

Identification and quantitation of novel metabolites of amiodarone in plasma of treated patients by Ha, Huy Riem, Bigler, Laurent, Wendt, Barbara, Maggiorini, Marco, Follath, Ferenc

“…In mammals, mono- N-desethylamiodarone (MDEA) is the only known metabolite of amiodarone. Our previous experiments demonstrated that in vitro MDEA may be…”
Get full text

Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man by Kupferschmidt, Hugo H. T., Fattinger, Karin E., Ha, Huy Riem, Follath, Ferenc, Krähenbühl, Stephan

“…Aims  Saquinavir is a potent HIV protease inhibitor whose effectiveness is limited in vivo by its low bioavailability. Since saquinavir is metabolized by…”
Get full text

Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe by Muntwyler, Jorg, Cohen-Solal, Alain, Freemantle, Nick, Eastaugh, Joanne, Cleland, John G., Follath, Ferenc

“…Aim: To study the role of sex, age and concomitant diseases for prescription of cardiovascular drugs among patients with heart failure cared for in the…”
Get full text

Etiology and response to drug treatment in heart failure by Follath, Ferenc, Cleland, John G.F, Klein, Werner, Murphy, Richard

“…Clinical trials in heart failure (HF) tend to randomize patients according to demographic characteristics and severity of left ventricular dysfunction, without…”
Get full text

Metabolism of antiarrhythmics by Ha, Huy Riem, Follath, Ferenc

“…Antiarrhythmics are a group of drugs that manage the irregular electrical activity of the heart. Their use in the clinic is made difficult by their narrow…”
Get more information

Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial by Thiele, Holger, Zeymer, Uwe, Thelemann, Nathalie, Neumann, Franz-Josef, Hausleiter, Jörg, Abdel-Wahab, Mohamed, Meyer-Saraei, Roza, Fuernau, Georg, Eitel, Ingo, Hambrecht, Rainer, Böhm, Michael, Werdan, Karl, Felix, Stephan B, Hennersdorf, Marcus, Schneider, Steffen, Ouarrak, Taoufik, Desch, Steffen, de Waha-Thiele, Suzanne

“…The role of intraaortic balloon counterpulsation (IABP) in cardiogenic shock is still a subject of intense debate despite the neutral results of the IABP-SHOCK…”
Get full text